May 1, 2024 · Form 4 insider transaction
MCKENZIE DIANA sold 1,168 shares of Vertex Pharmaceuticals Incorporated, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2023, Ms. McKenzie deferred the receipt of 1,168 shares of common stock and received instead 1,168 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,168 shares of common stock in exchange for an equal number of deferred stock units.